Technology | Heart Valve Technology
November 9, 2017 — 4C Medical Technologies Inc. announced that its medical device for mitral regurgitation (MR) was ...
November 09, 2017
Technology | Stents Drug Eluting
November 9, 2017 — Abbott received European CE mark for Xience Sierra, the newest generation of the company's Xience ...
November 09, 2017
Videos | Hemodynamic Support Devices
A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital ...
November 09, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Interventional Radiology
November 8, 2017 — Physicians at UnityPoint Health Methodist, Peoria, Ill., are now offering fast, safe and accurate ...
November 08, 2017
Videos | Structural Heart Occluders
John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the ...
November 08, 2017
Videos | Cath Lab
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on ...
November 08, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Stents
November 8, 2017 – New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report ...
November 08, 2017
News | FFR Technologies
Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual conference, Oct. 29-Nov. 2 in Denver.
November 08, 2017
News | Heart Valve Technology
Medtronic plc recently presented new clinical research to support the positive clinical performance of the Evolut Transcatheter Aortic Valve Replacement (TAVR) Platform in intermediate-risk, severe, symptomatic, aortic stenosis patients. Outcomes from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial and the Evolut R FORWARD “real-world” study were presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) Annual Meeting, Oct. 29-Nov. 2 in Denver, reinforcing the valve’s strong performance in healthier, more active patients.
November 08, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Videos | Heart Valve Technology
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...
November 08, 2017
Videos | Heart Valve Technology
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the ...
November 08, 2017
Videos | Stents Bioresorbable
A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian ...
November 07, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | Heart Valve Technology
November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and can ...
November 07, 2017
Videos | Heart Valve Technology
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of ...
November 07, 2017
News | Heart Valve Technology
November 7, 2017 — Medtronic plc recently presented positive data for its self-expanding Intrepid transcatheter mitral ...
November 07, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now